Back to Search
Start Over
Seroepidemiology of parechovirus A3 neutralizing antibodies, Australia, The Netherlands, and United States
- Source :
- Emerging infectious diseases, 25(1), 148-152. Centers for Disease Control and Prevention (CDC), Emerging Infectious Diseases, Vol 25, Iss 1, Pp 148-152 (2019), Emerging Infectious Diseases
- Publication Year :
- 2019
-
Abstract
- Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neutralizing antibody prevalence across all regions and time periods, indicating widespread circulation.
- Subjects :
- Male
Epidemiology
Parechovirus
lcsh:Medicine
Antibodies, Viral
Disease Outbreaks
0302 clinical medicine
Seroepidemiologic Studies
030212 general & internal medicine
Neutralizing antibody
Child
Netherlands
seroprevalence
Dispatch
neutralizing antibody
Middle Aged
Infectious Diseases
Child, Preschool
Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States
Female
Antibody
seroepidemiology
Microbiology (medical)
Adult
Adolescent
030231 tropical medicine
Picornaviruses
Biology
Herd immunity
lcsh:Infectious and parasitic diseases
03 medical and health sciences
Young Adult
Seroprevalence
Humans
viruses
lcsh:RC109-216
Picornaviridae Infections
Aged
outbreak
the Netherlands
lcsh:R
fungi
Australia
Outbreak
Infant
biology.organism_classification
Virology
Antibodies, Neutralizing
United States
Cross-Sectional Studies
parechovirus A3
biology.protein
Subjects
Details
- Language :
- English
- ISSN :
- 10806040
- Volume :
- 25
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Emerging infectious diseases
- Accession number :
- edsair.doi.dedup.....94107920111f946900125306c42850ab
- Full Text :
- https://doi.org/10.3201/eid2501.180352